Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
1926
Huya Inc
HUYA
$558M
| $2.44M | ﹤0.01% |
292,764
-15,940
| -5% | -$184K |
|
|
GES
1927
DELISTED
Guess Inc
GES
| $2.44M | ﹤0.01% |
115,953
+2,614
| +2% | +$59.8K |
|
|
ALTR
1928
DELISTED
Altair Engineering Inc
ALTR
| $2.42M | ﹤0.01% |
35,134
+9,159
| +35% | +$654K |
|
|
FOCS
1929
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.42M | ﹤0.01% |
46,259
+38,218
| +475% | +$1.95M |
|
1930
CEMIG Preferred Shares
CIG
$6.01B
| $2.41M | ﹤0.01% |
1,621,854
| – | – |
|
|
TPTX
1931
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.41M | ﹤0.01% |
36,333
+8,205
| +29% | +$585K |
|
1932
Coherus Oncology
CHRS
$196M
| $2.41M | ﹤0.01% |
149,864
+6,942
| +5% | +$102K |
|
1933
Tompkins Financial
TMP
$1.42B
| $2.4M | ﹤0.01% |
29,604
+2,745
| +10% | +$213K |
|
1934
iHeartMedia
IHRT
$583M
| $2.39M | ﹤0.01% |
95,643
+68,480
| +252% | +$1.69M |
|
1935
Pilgrim's Pride
PPC
$6.54B
| $2.38M | ﹤0.01% |
81,845
+6,958
| +9% | +$174K |
|
|
NTUS
1936
DELISTED
Natus Medical Inc
NTUS
| $2.38M | ﹤0.01% |
94,914
+6,931
| +8% | +$177K |
|
1937
Evolent Health
EVH
$447M
| $2.38M | ﹤0.01% |
76,763
+18,634
| +32% | +$447K |
|
1938
Inogen
INGN
$164M
| $2.37M | ﹤0.01% |
55,089
+6,987
| +15% | +$430K |
|
|
VRNT
1939
DELISTED
Verint Systems
VRNT
| $2.37M | ﹤0.01% |
52,961
+9,085
| +21% | +$395K |
|
1940
Calix
CALX
$2.39B
| $2.37M | ﹤0.01% |
47,952
+34,945
| +269% | +$1.61M |
|
1941
Endava
DAVA
$156M
| $2.37M | ﹤0.01% |
17,449
+4,184
| +32% | +$540K |
|
|
DOOR
1942
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.37M | ﹤0.01% |
22,317
-2,730
| -11% | -$310K |
|
|
AXNX
1943
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.37M | ﹤0.01% |
36,371
+27,395
| +305% | +$1.87M |
|
1944
Phreesia
PHR
$773M
| $2.36M | ﹤0.01% |
38,265
+31,864
| +498% | +$2.13M |
|
1945
Invesco Mortgage Capital
IVR
$805M
| $2.36M | ﹤0.01% |
74,923
-566
| -0.7% | -$18.4K |
|
1946
FuboTV Inc
FUBO
$273M
| $2.35M | ﹤0.01% |
8,172
+6,328
| +343% | +$2.07M |
|
1947
CEVA Inc
CEVA
$1.08B
| $2.35M | ﹤0.01% |
55,033
+4,820
| +10% | +$219K |
|
1948
Vir Biotechnology
VIR
$1.49B
| $2.35M | ﹤0.01% |
53,934
+9,254
| +21% | +$401K |
|
1949
Donnelley Financial Solutions
DFIN
$1.16B
| $2.34M | ﹤0.01% |
67,715
+5,594
| +9% | +$185K |
|
1950
Atlantic Union Bankshares
AUB
$5.97B
| $2.34M | ﹤0.01% |
63,489
+15,371
| +32% | +$553K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.